The next three years are the golden years when the value and potential of stem cell therapies will burst onto the medical scene. Now is the time for investors, surgeons, and business development executives to lay the foundations for future investments.

• Want to find out more about the companies that are bringing stem cells to surgeons and patients today?

• Interested in learning about the groundbreaking current and coming stem cell applications in the operating room as well as patient outcome data from the use of stem cells?

• Did you know that by 2016, companies supplying stem cell products should generate more than $1.2 billion in total revenues and have a combined market value of over $10 billion?

• Do you need to build awareness of your company with investors?

Join us in London’s financial center for the first Stem Cell Summit Europe, the largest gathering of stem cell company executives, scientists and investors to focus on the commercialization of stem cell products. In one day, you can get up to speed on this rapidly evolving industry, become familiar with the latest investment opportunities, and make invaluable contacts.

As a convenience for attendees, the Stem Cell Summit Europe will take place the day before Merrill Lynch’s Global Pharmaceutical, Biotech & Medtech Conference, also being held in London’s financial district.

An added benefit is the opportunity to observe a stem cell surgery and ask questions of the surgeon.

Registration required:

Yes

Free:

No